Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Results are not directly reported in the abstract; instead, it mentions studies related to treatments and observations in dermatological conditions like atopic dermatitis, psoriasis, alopecia areata, and other skin disorders, focusing on various interventions and potential advancements in these areas.

This study found that cortexolone 17α-propionate (clascoterone) effectively inhibited androgen receptor-regulated transcription and IL-6 synthesis in scalp cells, potentially making it a promising candidate for topical treatment of androgenetic alopecia.

In this mouse study, the researchers found that the monoclonal antibody ME1 causes hair follicle inflammation by up-regulating TNFα, which can be reduced by TNFα and interleukin-1 inhibitors.

This study found that specific TRPM5 modulators are unlikely to directly affect sebaceous glands, but safe TPPO analogues may provide moderate lipogenic and anti-inflammatory effects beneficial for dry skin conditions.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.